Search
Incyte Corp
INCYAdd to Watchlist
113.070USD
-0.200-0.18%
Close 10-16 16:00（ET）
22.92BMarket Cap
15.50P/E TTM
Incyte Corp (INCY) Stock Price Target & Forecast
Analyst Rating
Based on 29 analysts giving stock ratings to Incyte Corp in the past month.
Buy
6 Strong Buy
7 Buy
16 Hold
0 Sell
0 Strong Sell
Target Price
129.901USD+19.59%
INCY Analyst Recommendation Trends
In the current month, INCY has received 7 Buy Ratings, 16 Hold Ratings, and 0 Sell Ratings. INCY average Analyst price target in the last month is 129.901.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
6
6
6
6
6
6
6
7
7
7
6
6
5
5
5
5
16
16
16
15
17
15
15
14
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
29
29
28
27
29
27
27
27
INCY Analyst Rating for Peer Comparison
Updated: Oct 15, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Biogen Inc
BIIB
8
16
12
1
0
37
Amgen Inc
AMGN
4
9
19
3
1
36
AbbVie Inc
ABBV
8
19
6
0
0
33
Vertex Pharmaceuticals Inc
VRTX
10
17
5
0
1
33
Eli Lilly and Co
LLY
10
18
3
1
0
32
Alnylam Pharmaceuticals Inc
ALNY
7
17
8
0
0
32
Gilead Sciences Inc
GILD
7
18
6
0
0
31
Merck & Co Inc
MRK
7
16
8
0
0
31
Neurocrine Biosciences Inc
NBIX
13
14
4
0
0
31
Bristol-Myers Squibb Co
BMY
5
6
18
1
0
30
Financial Forecasting
Based on analysts' estimates, INCY EPS is projected to reach -3.618 in FY2026Q3, following reported EPS of 2.923 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
1.93
1.37
2.10
-3.62
1.98
Actual
1.52
1.52
2.92
--
--
Surprise
-21.37%
+10.99%
+39.06%
--
--
FAQs
What is Incyte Corp's expected revenue for the next quarter?
Incyte Corp's expected revenue is 1.47B.
What is Incyte Corp's price target?
Analysts forecast that Incyte Corp's price target is USD 129.86, with the highest forecast at USD 157.00 and the lowest forecast at USD 87.72.
How have Incyte CorpINCY's recent earnings per share performed?
The market expectation was USD 2.92, while Incyte CorpINCY's earnings per share (EPS) for the previous quarter was USD 1.52. EPS for the next quarter is expected at USD -3.62.
What is the analyst rating for Incyte Corp?
Based on the ratings of Incyte Corp's stock from 29 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.